Body composition–based nutritional status during neoadjuvant chemotherapy and its association with relative dose intensity and hematologic toxicity in patients with gastric cancer (opens in new tab)

ObjectiveThis study investigated changes in body composition before and after neoadjuvant therapy in patients with gastric cancer and explored the relationships between these changes, relative dose intensity (RDI), and hematological toxicity.MethodsBody composition parameters (muscle mass, skeletal muscle mass, body fat mass, visceral fat area, and water content) were measured via an InBody 720 analyzer before and after treatment. The primary outcome was a reduced RDI (<85%), and the secondar...